Teladoc Health, Inc.
TDOC
$6.36
-$0.25-3.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 83.09% | 79.99% | 77.23% | 79.38% | -334.44% |
| Total Depreciation and Amortization | -5.17% | -16.41% | -24.29% | -26.96% | -18.16% |
| Total Amortization of Deferred Charges | 13.71% | 25.99% | 35.08% | 45.59% | 48.15% |
| Total Other Non-Cash Items | -92.47% | -87.65% | -85.53% | -85.30% | 383.88% |
| Change in Net Operating Assets | 123.83% | 102.96% | 121.32% | 95.22% | -955.79% |
| Cash from Operations | -4.23% | 0.23% | -13.42% | -8.96% | -13.04% |
| Capital Expenditure | 36.71% | 17.58% | -104.65% | -14.28% | -20.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 73.23% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.31% | -54.69% | -33.77% | -31.12% | 0.85% |
| Cash from Investing | 15.37% | -114.43% | -99.62% | -77.39% | -44.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -63.49% | -62.89% | -48.78% | -58.99% | -23.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,462.26% | -205,300.00% | -28.32% | 94.96% | 78.80% |
| Cash from Financing | -7,669.85% | -6,736.81% | -12,395.11% | -6,274.80% | -20.77% |
| Foreign Exchange rate Adjustments | 545.15% | 284.15% | -1.15% | 484.33% | -245.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -563.95% | -396.16% | -342.63% | -337.01% | -54.43% |